MXL vs TMO · rev $360.5M vs P/E 24, rev $44.56B
MaxLinear Inc (MXL) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
MaxLinear Inc (MXL) is a semiconductors company listed on NASDAQ.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported MXL revenue for 2024-12-31 was $360.5M. Net income was -$245.2M. Revenue was down 48.0% from 2023-12-31 to 2024-12-31. MXL currently screens at market cap $7.42B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
MXL currently screens at market cap $7.42B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the MXL and TMO stock pages for the full models.
Not investment advice.